🇺🇸 FDA
Patent

US 9044442

Peptidomimetic compounds as immunomodulators

granted A61KA61K31/16A61K31/197

Quick answer

US patent 9044442 (Peptidomimetic compounds as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/16, A61K31/197, A61K31/222, A61K31/405